Evidence map›Paper›PMID 25913378›Full record

ArticleInternational journal of molecular sciences2015

Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.

Karina Miranda Santiago, Amanda França de Nóbrega, Rafael Malagoli Rocha, Silvia Regina Rogatto, Maria Isabel Achatz

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.Indian journal of dermatology, venereology and leprology
    Pooled it
  3. Xeroderma Pigmentosum: General Aspects and Management.Journal of personalized medicine · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karina Miranda SantiagoInternational Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010, Brazil. amanda.nobrega@accamargo.org.br.
Amanda França de NóbregaDepartment of Oncogenetics, A.C. Camargo Cancer Center, São Paulo, SP 01509-900, Brazil. amanda.nobrega@accamargo.org.br.
Rafael Malagoli RochaMolecular Morphology Group, Investigative Pathology Department, A.C. Camargo Cancer Center, São Paulo, SP 01509-900, Brazil. rafael.malagoli@gmail.com.
Silvia Regina RogattoInternational Research Center, A.C. Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics (INCITO), São Paulo, SP 01508-010, Brazil.
Maria Isabel AchatzDepartment of Oncogenetics, A.C. Camargo Cancer Center, São Paulo, SP 01509-900, Brazil. miachatz@cipe.accamargo.org.br.
AC Camargo Hospital · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by DNA repair defects that cause photophobia, sunlight-induced cancers, and neurodegeneration. Prevalence of germline mutations in the nucleotide excision repair gene XPA vary significantly in different populations. No Brazilian patients have been reported to carry a germline mutation in this gene. In this study, the germline mutational status of XPA was determined in Brazilian patients exhibiting major clinical features of XP syndrome. The study was conducted on 27 unrelated patients from select Brazilian families. A biallelic inactivating transition mutation c.619C>T (p.Arg207Ter) was identified in only one patient with a history of neurological impairment and mild skin abnormalities. These findings suggest that XP syndrome is rarely associated with inherited disease-causing XPA mutations in the Brazilian population. Additionally, this report demonstrates the effectiveness of genotype-phenotype correlation as a valuable tool to guide direct genetic screening.

Indexed as

AdolescentBrazilDNA Mutational AnalysisFemaleGerm-Line MutationHumansMalePrevalenceXeroderma PigmentosumXeroderma Pigmentosum Group A ProteinXeroderma Pigmentosum Group A ProteinXPA protein, human

Identifiers

PMID25913378
PMCPMC4425119
OpenAlexW2082591423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.